Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Simonson

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Diabetes|August 1, 1985
Clinical predictors of retinopathy and its progression in patients with type I diabetes during CSII or conventional insulin treatmentM A Testa, J E Puklin, R S Sherwin, et al.
Diabetes|July 1, 1988
Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone releaseS A Amiel, R S Sherwin, D C Simonson, et al.
The Journal of Clinical Investigation|December 1, 1987
Effect of insulin and plasma amino acid concentrations on leucine metabolism in man. Role of substrate availability on estimates of whole body protein synthesisP Castellino, L Luzi, D C Simonson, et al.
American Journal of Hypertension|October 1, 1992
Disparate effects of weight loss on insulin sensitivity and erythrocyte sodium-lithium countertransport activityH A Wolpert, S N Steen, N W Istfan, et al.
Annals of Internal Medicine|August 1, 1985
Intensive insulin therapy reduces counterregulatory hormone responses to hypoglycemia in patients with type I diabetesD C Simonson, W V Tamborlane, R A DeFronzo, et al.
The New England Journal of Medicine|May 28, 1987
Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitusS A Amiel, W V Tamborlane, D C Simonson, et al.
Metabolism: Clinical and Experimental|August 1, 1993
Insulin modulates circulating endothelin-1 levels in humansH A Wolpert, S N Steen, N W Istfan, et al.
Diabetes Care|April 1, 1997
Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM. Results of two multicenter, randomized, placebo-controlled clinical trials. The Glipizide Gastrointestinal Therapeutic System Study GroupD C Simonson, I A Kourides, M Feinglos, et al.
The American Journal of Physiology|February 1, 1988
Normalization of carbohydrate-induced thermogenesis by fructose in insulin-resistant statesD C Simonson, L Tappy, E Jequier, et al.
Diabetes|January 1, 1990
Leucine metabolism in IDDM. Role of insulin and substrate availabilityL Luzi, P Castellino, D C Simonson, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Diabetes|August 1, 1985
Clinical predictors of retinopathy and its progression in patients with type I diabetes during CSII or conventional insulin treatmentM A Testa, J E Puklin, R S Sherwin, et al.
Diabetes|July 1, 1988
Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone releaseS A Amiel, R S Sherwin, D C Simonson, et al.
The Journal of Clinical Investigation|December 1, 1987
Effect of insulin and plasma amino acid concentrations on leucine metabolism in man. Role of substrate availability on estimates of whole body protein synthesisP Castellino, L Luzi, D C Simonson, et al.
American Journal of Hypertension|October 1, 1992
Disparate effects of weight loss on insulin sensitivity and erythrocyte sodium-lithium countertransport activityH A Wolpert, S N Steen, N W Istfan, et al.
Annals of Internal Medicine|August 1, 1985
Intensive insulin therapy reduces counterregulatory hormone responses to hypoglycemia in patients with type I diabetesD C Simonson, W V Tamborlane, R A DeFronzo, et al.
The New England Journal of Medicine|May 28, 1987
Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitusS A Amiel, W V Tamborlane, D C Simonson, et al.
Metabolism: Clinical and Experimental|August 1, 1993
Insulin modulates circulating endothelin-1 levels in humansH A Wolpert, S N Steen, N W Istfan, et al.
Diabetes Care|April 1, 1997
Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM. Results of two multicenter, randomized, placebo-controlled clinical trials. The Glipizide Gastrointestinal Therapeutic System Study GroupD C Simonson, I A Kourides, M Feinglos, et al.
The American Journal of Physiology|February 1, 1988
Normalization of carbohydrate-induced thermogenesis by fructose in insulin-resistant statesD C Simonson, L Tappy, E Jequier, et al.
Diabetes|January 1, 1990
Leucine metabolism in IDDM. Role of insulin and substrate availabilityL Luzi, P Castellino, D C Simonson, et al.
Pageof 8